Recent data suggest that sub-clinical structural abnormalities may be part of the Brugada syndrome (BrS) phenotype, a disease traditionally thought to occur in the structurally normal heart. In this study, we carried out detailed assessment of cardiac morphology and function using cardiac magnetic resonance imaging (CMRI).
Introduction
The Brugada syndrome (BrS) is an inherited cardiac disease associated with a high risk of ventricular tachyarrhythmias and sudden cardiac death in young and otherwise healthy adults. It is characterized by an electrocardiographic pattern of complete or incomplete right bundle branch block (RBBB) and by a dynamic ST-segment elevation in the right precordial leads (V 1 -V 3 ). 1 -3 BrS has been linked to mutations in the SCN5A gene located on chromosome 3, which encodes for the alpha subunit of the cardiac sodium channel. 4 -8 More recently, additional ion channels and ion channel-regulating genes have been identified. Therefore, for many years BrS has been considered a purely electrical disease even if, more recently, some authors have suggested the presence of morphological and functional abnormalities in patients with BrS, predominantly located in the right ventricle (RV) and specifically in the outflow tract (RVOT). 9 -13 Cardiac magnetic resonance imaging (CMRI), thanks to its high spatial resolution, the lack of interferences with the extracardiac structures, the possibility of acquiring kinetic images, and the ability to provide tissue characterization, allows a high-quality assessment of cardiac morphology and function. CMRI is an accurate and reproducible tool for evaluating the RV, which is often difficult to assess with other imaging techniques. So far, only one study evaluated CMRI features of BrS patients. 14 Unfortunately, only standard axial sections were used for measurements, which are now considered only a part of CMRI acquisition protocols for arrhythmogenic cardiac diseases assessment. 15 Here, we aimed at performing detailed quantification of several CMRI parameters in a cohort of consecutive patients suffering from BrS to further exploit the hypothesis that mild or subclinical structural abnormalities may be present in this disease.
Methods Study design and population
Thirty consecutive BrS patients were included in the study and were compared with 30 sex-(26/4 male/female), body surface area-(BSA; +0.2 m 2 ), and age-matched (+5 years) normal volunteers (mean BSA: 1.87 + 0.14 vs. 1.86 + 0.18 m 2 ; mean age: 39 + 12 vs. 38 + 11 years, respectively). Control subjects were recruited among our hospital workers; 30 out of 32 contacted subjects adhered to our request. Exclusion criteria for normal volunteers were the presence of signs or symptoms of cardiac diseases, hypertension, diabetes, smoking (more than 10 cigarettes a day for more than 10 years), or being engaged in competitive sports. At the end of recruitment, independently from the original matching, we checked for the best matching in terms of age and BSA. Study sample size estimation was based on a conservative interpretation of a previous study by Bellenger et al., 16 suggesting a minimum sample size of 10 -15 patients to detect significant differences in the left ventricle (LV) parameters.
Diagnosis of BrS was based on the criteria reported in the consensus conference. 3 The presence/absence of spontaneous ECG pattern was assessed on resting ECG and with standard positioning of right precordial leads with no upper displacement. Arrhythmogenic right ventricle cardiomyopathy (ARVC) was carefully excluded with electrocardiographic and morphological assessments and no patient with .1 major or .2 minor criteria for ARVC diagnosis was included. Moreover, family history of ARVC was ruled out up to the second-degree relatives in order to try to avoid the possibility of recessive variants. The study was approved by the Institutional Review Board. An informed consent to undergo CMRI was signed by all subjects.
Molecular analysis
DNA was extracted by means of standard procedures. The entire open reading frame of the SCN5A gene was PCR-amplified using specific primer pairs. 6 Each amplicon was analysed using highperformance liquid chromatography (Wave, Transgenomic, Omaha, NE, USA) with at least two fragment-specific melting temperatures. Abnormal chromatograms were directly sequenced or cloned (Topo-TA cloning, Invitrogen, Milan, IT, USA) and sequenced on both strands with an automated DNA analyzer (ABI Prism 310, Applied Biosystems, Foster City, CA, USA). A panel of 400 healthy individuals (800 alleles) was used as control.
Magnetic resonance imaging
CMRI study was performed using a 1.0-Tesla scanner with a dynamic gradient of 20 mT (Magneton Harmony, Siemens, Erlangen, Germany) and a phased-array cardiac coil. In all subjects, we acquired morphological and dynamic images of the heart in the long-axis (two-, three-, and four-chambers) as well as in the short-axis view [a stack of 6-10 slices from atrioventricular (AV) valvular plane to the apex]. In BrS patients two stacks of oblique axial planes with four to five planes parallel to the four-chamber long-axis plane, covering the inflow of the RV, and four to five planes parallel to the three-chamber long-axis plane, covering the outflow, were also acquired. 
Images analysis
Off-line images analysis was performed by two experienced readers (O.C. and S.A.), blind with respect to clinical status of the subjects. Regional contractility (hypokinesis, akinesis, dyskinesia) of the LV on the cine images and fatty infiltration (high-intensity signal within myocardium) of both ventricles on T1-weighted TSE images were visually identified by consensus of the two readers.
RV regional contractility was quantitatively assessed, as described in Figure 1 , by evaluating radial fractional shortening [(diastolic radius 2 systolic radius)/diastolic radius Â 100%] in each of eight segments in which RV-free wall was divided (three basal, three mid-ventricular, and two apical). We identified segments with reduced contractility as those with a fractional shortening value under the 25th percentile of the segment-specific pooled values (BrS plus normal subjects). Moreover, tricuspidal annular plane systolic excursion (TAPSE), that is RV apical to base shortening was evaluated to explore longitudinal shortening component of RV inflow tract (RVIT) contraction.
A series of mono-dimensional measurements of both LV and RV were obtained at end-diastole, about 1 cm below the AV valve plane ( Figure 2 ). The area of both atria was measured at end-systole on the four-chamber slice. On the short-axis slice closest to tricuspidalic plane with RVIT and RVOT chambers in full continuity, we measured the areas of both inflow and outflow parts of the RV (Figure 3) .
Quantitative analysis of cine images was performed using commercial software (ARGUS, Siemens). Through semi-automatic contouring of endocardial and epicardial borders end-diastolic volumes (EDV), end-systolic volumes (ESV), ejection fraction (EF), and mass of both the LV and the RV were calculated. EDV and ESV, independently for the two ventricles, were defined by visually assessing the frames with the greatest and the smallest cavity areas using a short-axis slice at mid-ventricular level. The most basal slice included in the analysis was that with the outflow tract no longer visible for the LV, and with the inflow and the outflow chambers in full continuity for the RV.
Regional volumes and ejection fraction of RVIT and RVOT were also assessed using the same commercial software but with manual tracing of endocardial border. Supraventricular crista, the moderator band, the anterior papillary muscle, and the anterior cuspid of tricuspid valve were the anatomic markers used to distinguish the inflow part from the outflow part of RV cavity.
Statistical analysis
Categorical variables are presented as counts or percentages, quantitative variables as means + SD. Student's paired t-test was used for comparison of quantitative variables. Pearson's x 2 was used to test differences of categorical variables. P , 0.05 (two-sided) was considered statistically significant in all tests. Bonferroni correction was applied to manage multiple testing when we analysed differences about several cardiac segments, areas, and volumes (26 variables, P , 0.002 ¼ 0.05/26). Conditional logistic regression was used to investigate the association between BrS diagnosis (dependent variable) and RV regional contractility, simultaneously introduced into the model as eight covariates (differences between the case and the control values for the eight RV segments).
To assess intra-and inter-observer reproducibility of RVIT diameter (representative of all mono-dimensional measures) and of radial fractional shortening assessments, two blinded investigators (O.C. and S.A.) evaluated 20 randomly selected subjects among the study population (10 subjects, equal to 80 segments, for radial fractional shortening), and one of them repeated the measurements at least 1 week after the first evaluation. We calculated Bland -Altman mean difference (bias) and coefficients of repeatability (CoR ¼ 1.96 Â sqrt (2) Â sw; where sw is the within-subject SD). We approached the problem of multiple segments per patient by following the method described by Bland -Altman in the case of multiple observations per individual. 17 RVIT diameter intra-and inter-observer mean difference (bias) were 0 and 0 mm, with CoR of 2.5 and 3.5 mm, respectively. Radial fractional shortening intra-and inter-observer biases were 21 and 1%, with CoRs of 18 and 23%, respectively. Bland -Altman plots are shown as Supplementary material online.
Results
The clinical, electrocardiographic, and genetic characteristics of patients with BrS are listed in Table 1 . One-quarter of cases had a positive family history for sudden cardiac death (8/30, 27%) and syncope was reported (5/30, 17%) in patients. Standard 12-lead ECG showed spontaneous coved-type pattern in 10 (33%) patients, while the remaining had a diagnostic type 1 ECG pattern upon challenge with class Ic drug (Ajmaline 1 mg/kg i.v.). AV conduction delay and a complete or incomplete RBBB were present in 4 (13%) and 26 (87%) of controls and patients, respectively. Genetic screening identified a mutation in the SCN5A gene in nine patients (30%). Four mutations were nonsense or frame-shift leading to a truncated protein. Among the remaining five mutations, two were already reported in the literature (www.fsm .it/cardmoc). One patient was a compound heterozygous of two novel mutations, one truncation and one missense.
Wall motion assessment
At CMRI evaluation, none of patients or normal subjects showed fatty infiltration of the RV or LV. However, a significant high percentage of BrS patients presented with mild RV wall motion abnormalities in more than two segments [15 (50%) 
Right and left ventricle morphology
LV and RV dimensional and functional parameters as well as atrial areas are listed in Table 2 . Patients with BrS showed larger RV ESV (34 + 9 vs. 30 + 6 mL/m 2 ; P ¼ 0.031) but comparable RV EDV, EF, and mass respect to normal volunteers. LV assessment disclosed only slight interventricular septum thickening in BrS patients (9.5 + 1.1 vs. 9.0 + 1.1; P ¼ 0.030), while there was no difference in terms of diameter, volumes, function, and mass. The area of both atria was similar in the two groups also. , P ¼ 0.528) but regional RVOT ejection fraction was lower in BrS patients (49 + 11 vs. 55 + 10%; P ¼ 0.032), because of an augmented RVOT ESV (13 + 4 vs. 11 + 3 mL/m 2 ; P ¼ 0.047). Among all dimensional and functional parameters listed in Table 2 , only RVIT diameter was significantly different between BrS patients and normal volunteers after Bonferroni correction. Figure 4 depicts a representative BrS case with RVIT enlargement, compared to a control subject.
In the BrS group, the presence of enlarged RVIT, i.e. larger than the 75 percentile of the normal group values, did not correlate with the clinical presentation: family history of sudden death, history of syncope, spontaneous coved-type ECG pattern, AV or intraventricular conduction delay, or the presence of a mutation in the SCN5A gene.
Discussion
The BrS is a relatively frequent inherited arrhythmogenic syndrome. It is characterized by an electrocardiographic pattern of complete or incomplete RBBB and dynamic ST-segment elevation in the right precordial leads (V 1 -V 3 ) . The BrS was proposed as a new and distinct clinical entity in 1992 by Brugada and Brugada, 18 who described eight patients with a history of aborted sudden cardiac death owing to ventricular fibrillation, a typical electrocardiographic pattern and the absence of any structural heart disease. SCN5A gene encoding for the alpha subunit of the sodium channel gene has been associated with the phenotype of BrS and it represents the most prevalent genetic variant. More recently, other authors reported mutation on GPD1-L (glycerol-phosphate dehydrogenase-1 like), 19 and the cardiac calcium channel. 20 Despite the original description of BrS excluded structural abnormalities, anecdotal observations on small patients' cohorts suggested the presence of RV abnormalities. Atrophy, fatty or fatty infiltration, at endomyocardial biopsy and/or autopsy, or morphofunctional abnormalities at echocardiography (dilatation and dysfunction) were also reported in the literature.
9,21 Furthermore, other authors suggested that ST-segment elevation in right precordial leads may be present in patients with ventricular fibrillation and RV cardiomyopathy. 10 Diagnostic work out and follow-up of patients with BrS often includes transthoracic echocardiography (TTE) imaging, which has low sensitivity to detect RV abnormalities. Indeed, although TTE is sufficiently precise for the assessment of LV, it does not allow an accurate evaluation of the RV volumes and segmental contractility. Moreover, an adequate tissue characterization cannot be performed with TTE.
Wall motion abnormalities
Only one study has so far reported an abnormal contractility of the RV in the BrS patients. Using electron beam computed tomography, Takagi Despite the unavoidable differences of the clinical characteristics of study cohorts, it is clear that the evidence supporting a structural involvement of the RV also determining mild wall motion abnormalities in this disease is accumulating.
Right ventricular enlargement
Papavassiliu et al.
14 have previously shown a significant enlargement of the RVOT area at CMRI in 20 BrS patients in comparison with age-and sex-matched normal controls.
In the present study, we did not find RVOT enlargement in BrS patients with respect to normal subjects. On the contrary, in our series of BrS patients, a significant enlargement of the RVIT diameter was detected both in the short-axis (46 + 4 mm vs. 41 + 5 mm; P , 0.001) and in the long-axis view (46 + 4 vs. 42 + 5; P ¼ 0.001), and was the sole dimensional parameter significantly different after Bonferroni correction for multiple testing.
There are relevant methodological differences in the two studies: we used double-oblique cardiac-oriented views, sectioning RVOT with approximately the same angle with respect to its major axis; on the contrary Papavassiliu et al. measured RVOT on standard axial slices, then sectioning RVOT with an angle that varied according to the orientation of the heart in the chest. A more careful re-analysis of the study by Papavassiliu et al. highlights the presence of a larger RVIT diameter (EDD) among BrS patients, like in our study, on short-axis cardiac-oriented planes. Therefore, the discrepancy may be owing to methodological differences. Nonetheless, both studies (Papavassiliu and ours) clearly suggest that RV structural abnormalities may be present in some BrS patients (9/30 patients in our series).
Fatty infiltration
In the present study no fatty replacement of the RV was observed in any patient. Papavassiliu et al. reported this finding in 20% of the patients. It is unknown why the fatty replacement, frequently found at the endomyocardial biopsy or at post-mortem examination, 9, 10 is rarely observed with CMRI. In normal hearts, fat is present on the epicardial surface of the RV and around the coronary blood vessels, in amount varying with an individual's age and sex. 22 Therefore, it is possible that the pathological meaning of bioptic or autoptic findings has been overestimated. Alternatively, fatty replacement might be present only in the most severe cases. Finally, a low rate of fat discovered in our study may derive from a more conservative approach to the problem, the RV wall being too thin (2-3 mm) to make robust statements on the real localization of fat (inside or outside the muscular wall).
Limitations of the study
Fibrotic replacement of the RV myocardium has been shown by delayed enhancement at CMR in small studies including patients with ARVC. 23, 24 Delayed enhancement technique is proposed in the 'CMR Image acquisition Protocols' of the Society for Cardiovascular Magnetic Resonance for ARVC assessment. Our study was not originally designed to acquire this kind of information.
Even if we took a conservative approach and we did not enrol patients having .1 major or .2 minor ARVC diagnosis criteria, or with ARVC diagnosis in relatives up to the second degree, this is a potential limitation of the study. The radial fractional shortening method, we used to assess RV contractility, may not differentiate passive inward movement from active contraction of RV wall. Unfortunately, RV systolic myocardial thickening cannot be accurately assessed by CMRI (although it has good spatial resolution) owing to the very thin RV wall, and could not be considered as an alternative method.
Conclusions
In this study we carried out a detailed targeted morphological analysis of the RV in a consecutive cohort of BrS patients and we provide the final proof of concept that a clinically relevant percentage of BrS patient present with RV enlargement or mild wall motion abnormalities. As expected based on the 'electrical nature' of BrS, such abnormalities are of relatively small magnitude, but they are definitely present, as demonstrated with conditional logistic regression and supported by reproducibility analysis of our approach. Our findings are consistent and further refine previous data and suggest that BrS phenotype and pathophysiology are more complex than previously anticipated. We found no correlation between structural/motion abnormalities and the clinical presentation (family history of sudden death, history of syncope, spontaneous coved-type ECG pattern, AV or intraventricular conduction delay); however our study was not targeted to this endpoint and the relatively limited sample size could have hampered the statistical power to detect such correlation.
Furthermore, although it is well known that SCN5A mutations may be directly implicated in cardiomyopathies, such as degenerative changes in the conduction system (Lenegre disease) and dilated cardiomyopathy, 25 -27 we found no correlation between the presence of a sodium channel mutation and RV abnormalities in our patients. Once again our data point to the increasing complexity of the definition of BrS, which is the clinical expression of a non-uniform pathogenesis. Nonetheless, our study has a direct clinical implication since it definitely proves the structural involvement of the RV in BrS and suggests the need of performing careful morphological assessment of the RV in all patients. It is currently unknown whether such structural abnormalities may worsen at follow-up if they may have a role in risk stratification. These issues should be the focus of future studies.
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